Tocqueville Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14M Sell
91,898
-22,937
-20% -$3.52M 0.21% 126
2025
Q4
$15.8M Sell
114,835
-1,067
-0.9% -$140K 0.23% 120
2025
Q3
$14.9M Sell
115,902
-412
-0.4% -$50.3K 0.22% 124
2025
Q2
$14.1M Sell
116,314
-1,179
-1% -$133K 0.21% 124
2025
Q1
$13.1M Sell
117,493
-1,420
-1% -$151K 0.21% 114
2024
Q4
$11.6M Buy
118,913
+11,395
+11% +$1.22M 0.18% 126
2024
Q3
$12.4M Sell
107,518
-2,758
-3% -$313K 0.19% 124
2024
Q2
$11.7M Buy
110,276
+1,737
+2% +$174K 0.19% 120
2024
Q1
$10.5M Buy
108,539
+503
+0.5% +$51.6K 0.17% 130
2023
Q4
$10.9M Sell
108,036
-7,215
-6% -$696K 0.2% 122
2023
Q3
$11.7M Buy
115,251
+640
+0.6% +$65K 0.22% 120
2023
Q2
$11.6M Sell
114,611
-63,613
-36% -$6.36M 0.21% 122
2023
Q1
$16.4M Sell
178,224
-3,097
-2% -$270K 0.31% 92
2022
Q4
$16.4M Sell
181,321
-58
-0% -$4.88K 0.31% 94
2022
Q3
$13.8M Sell
181,379
-3,281
-2% -$272K 0.28% 98
2022
Q2
$15.6M Sell
184,660
-192
-0.1% -$16.8K 0.29% 91
2022
Q1
$16.2M Sell
184,852
-8,085
-4% -$700K 0.25% 107
2021
Q4
$16.9M Sell
192,937
-57,164
-23% -$4.75M 0.23% 105
2021
Q3
$20.5M Sell
250,101
-1,863
-0.7% -$168K 0.3% 87
2021
Q2
$23M Sell
251,964
-45,703
-15% -$4.07M 0.33% 80
2021
Q1
$25.4M Sell
297,667
-9,628
-3% -$864K 0.39% 62
2020
Q4
$29M Sell
307,295
-6,450
-2% -$564K 0.48% 48
2020
Q3
$27.3M Sell
313,745
-6,273
-2% -$543K 0.52% 43
2020
Q2
$27.9M Buy
320,018
+37,475
+13% +$3.23M 0.58% 37
2020
Q1
$23.3M Sell
282,543
-27
-0% -$2.41K 0.58% 41
2019
Q4
$26.8M Sell
282,570
-71,531
-20% -$6.42M 0.39% 67
2019
Q3
$30.8M Sell
354,101
-28,404
-7% -$2.55M 0.42% 64
2019
Q2
$34.9M Sell
382,505
-68,564
-15% -$5.8M 0.45% 60
2019
Q1
$38.9M Sell
451,069
-72,478
-14% -$5.82M 0.52% 53
2018
Q4
$40.3M Sell
523,547
-71,448
-12% -$5.56M 0.6% 41
2018
Q3
$45.9M Buy
594,995
+7,944
+1% +$587K 0.58% 42
2018
Q2
$39.7M Buy
587,051
+17,633
+3% +$1.22M 0.5% 52
2018
Q1
$41.3M Sell
569,418
-58,026
-9% -$4.42M 0.53% 49
2017
Q4
$47.2M Buy
627,444
+34,674
+6% +$2.62M 0.54% 50
2017
Q3
$45.6M Buy
592,770
+39,060
+7% +$2.95M 0.52% 51
2017
Q2
$41.4M Buy
553,710
+58,031
+12% +$4.11M 0.5% 49
2017
Q1
$33M Buy
495,679
+44,822
+10% +$2.99M 0.4% 66
2016
Q4
$29.4M Sell
450,857
-8,493
-2% -$551K 0.38% 71
2016
Q3
$32.5M Buy
459,350
+30,209
+7% +$2.2M 0.39% 66
2016
Q2
$31.7M Buy
429,141
+37,737
+10% +$2.61M 0.38% 63
2016
Q1
$25.4M Buy
391,404
+100,022
+34% +$6.8M 0.34% 85
2015
Q4
$22.5M Buy
291,382
+4,924
+2% +$391K 0.3% 98
2015
Q3
$23.6M Sell
286,458
-4,701
-2% -$418K 0.32% 98
2015
Q2
$25.7M Buy
291,159
+12,966
+5% +$1.19M 0.3% 105
2015
Q1
$24.6M Sell
278,193
-95,113
-25% -$8.44M 0.29% 110
2014
Q4
$31M Sell
373,306
-60,594
-14% -$5.02M 0.33% 99
2014
Q3
$36.6M Sell
433,900
-1,021
-0.2% -$82.6K 0.41% 81
2014
Q2
$35.3M Buy
+434,921
New +$34.2M 0.34% 93
2013
Q4
Sell
-458,206
Closed -$31.5M 1399
2013
Q3
$31.5M Sell
458,206
-2,818
-0.6% -$186K 0.39% 88
2013
Q2
$29.2M Buy
+461,024
New +$30M 0.4% 86

Other funds holding NVS

Tocqueville Asset Management's NVS Position: Q1 2026 in Review

Tocqueville Asset Management reduced its Novartis (NVS) stake by 20% in Q1 2026, selling an estimated $3.52M and leaving 91,898 shares worth $14M. The position accounts for 0.21% of the portfolio, ranked #126.

Tocqueville Asset Management first reported a position in NVS in Q2 2013 and has held it in 50 quarters since. The position peaked at $47.2M in Q4 2017. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Tocqueville Asset Management held 91,898 shares of Novartis worth $14M as of Q1 2026.
  • Tocqueville Asset Management sold 22,937 Novartis shares in Q1 2026, an estimated $3.52M.
  • Novartis made up 0.21% of Tocqueville Asset Management's portfolio in Q1 2026, its #126 holding.
  • Tocqueville Asset Management first reported a position in Novartis in Q2 2013 and has held it in 50 quarters since.
  • Tocqueville Asset Management's Novartis position peaked at $47.2M in Q4 2017.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Tocqueville Asset Management's 13F filing for Q1 2026, filed 12 May 2026.